Detection of point mutations associated with antibiotic resistance in Pseudomonas aeruginosa

被引:57
作者
Gorgani, Neda [1 ,4 ]
Ahlbrand, Scott [3 ]
Patterson, Andrew [3 ]
Pourmand, Nader [1 ,2 ]
机构
[1] Stanford Univ, Stanford Genome Technol Ctr, Palo Alto, CA 94304 USA
[2] Univ Calif Santa Cruz, Santa Cruz, CA 95064 USA
[3] Stanford Univ, Sch Med, Palo Alto, CA 94305 USA
[4] San Jose State Univ, Dept Biol Sci, San Jose, CA 95192 USA
基金
美国国家科学基金会; 美国国家卫生研究院;
关键词
Pyrosequencing; Pseudomonas aeruginosa; Antibiotic resistance; INTENSIVE-CARE-UNIT; ANTIMICROBIAL RESISTANCE; GYRA MUTATIONS; MECHANISMS; DNA;
D O I
10.1016/j.ijantimicag.2009.05.013
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Excessive use of broad-spectrum antibiotics in hospitals has led to the emergence of highly resistant strains of Pseudomonas aeruginosa. To reduce the selection pressure for resistance, it is important to determine the antibiotic susceptibility pattern of bacteria so that hospital patients can be treated with more narrow-spectrum and target-specific antibiotics. This study describes the development of a technique for detecting point muations in the fluoroquinolone resistance-determining region of the gyrA and parC genes as well as the efflux regulatory genes mexR, mexZ and mexOZ that are associated with fluoroquinolone and aminoglycoside resistance. The assay is based on a short DNA sequencing method using multiplex-fast polymerase chain reaction (PCR) and Pyrosequencing (TM) for amplification and sequencing of the selected genes. Fifty-nine clinical isolates of P. aeruginosa were examined for mutations in the abovementioned genes. Mutations related to antibiotic resistance were detected in codons 83 and 87 of gyrA and codon 126 of the mexR regulatory gene. Results of this study suggest Pyrosequencing (TM) as a substitute for traditional methods as it provides a rapid and reliable technique for determining the antibiotic resistance pattern of a given bacterial strain in <1 h. (C) 2009 Elsevier B.V. and the International Society of Chemotherapy. All rights reserved.
引用
收藏
页码:414 / 418
页数:5
相关论文
共 14 条
[1]   Involvement of an active efflux system in the natural resistance of Pseudomonas aeruginosa to aminoglycosides [J].
Aires, JR ;
Köhler, T ;
Nikaido, H ;
Plésiat, P .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1999, 43 (11) :2624-2628
[2]   Rational use of antibiotics in the intensive care unit: impact on microbial resistance and costs [J].
Geissler, A ;
Gerbeaux, P ;
Granier, I ;
Blanc, P ;
Facon, K ;
Durand-Gasselin, J .
INTENSIVE CARE MEDICINE, 2003, 29 (01) :49-54
[3]   Detection of gyrA mutations associated with ciprofloxacin resistance in Neisseria gonorrhoeae by rapid and reliable pre-programmed short DNA sequencing [J].
Gharizadeh, B ;
Akhras, M ;
Unemo, M ;
Wretlind, B ;
Nyrén, P ;
Pourmand, N .
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2005, 26 (06) :486-490
[4]   Large-scale pyrosequencing of synthetic DNA: A comparison with results from Sanger dideoxy sequencing [J].
Gharizadeh, Baback ;
Herman, Zelek S. ;
Eason, Robert G. ;
Jejelowo, Olufisayo ;
Pourmand, Nader .
ELECTROPHORESIS, 2006, 27 (15) :3042-3047
[5]   Expression of the MexXY efflux pump in amikacin-resistant isolates of Pseudomonas aeruginosa [J].
Islam, S ;
Jalal, S ;
Wretlind, B .
CLINICAL MICROBIOLOGY AND INFECTION, 2004, 10 (10) :877-883
[6]   Molecular mechanisms of fluoroquinolone resistance in Pseudomonas aeruginosa isolates from cystic fibrosis patients [J].
Jalal, S ;
Ciofu, O ;
Hoiby, N ;
Gotoh, N ;
Wretlind, B .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2000, 44 (03) :710-712
[7]   Mechanisms of quinolone resistance in clinical strains of Pseudomonas aeruginosa [J].
Jalal, S ;
Wretlind, B .
MICROBIAL DRUG RESISTANCE-MECHANISMS EPIDEMIOLOGY AND DISEASE, 1998, 4 (04) :257-261
[8]   Strategies to prevent antimicrobial resistance in the intensive care unit [J].
Kollef, MH ;
Micek, ST .
CRITICAL CARE MEDICINE, 2005, 33 (08) :1845-1853
[9]  
Lambert PA, 2002, J ROY SOC MED, V95, P22
[10]   Multiple mechanisms of antimicrobial resistance in Pseudomonas aeruginosa:: Our worst nightmare? [J].
Livermore, DM .
CLINICAL INFECTIOUS DISEASES, 2002, 34 (05) :634-640